Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

Receptor residence time trumps drug-likeness and oral bioavailability in determining efficacy of complement C5a antagonists.

  • Post by:
  • May 23, 2019
  • Comments off
Categories: